Yeh Lab
Located within the UNC Lineberger Comprehensive Cancer Center, the Yeh Lab’s focus is to identify and study novel therapeutic targets for the treatment of pancreatic cancer. Pancreatic cancer in particular continues to be a lethal disease with few therapeutic options. Our research therefore centers on target identification through genomic, and more recently proteomic analyses of patient samples.
Learn More
Research
-
Congrats Des
Des Weighill, PhD, received The NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers in July 2022. Des has also received the Hopper-Belmont Foundation Inspiration Award in September 2022, and most recently received the APA 2022 Young Investigator Travel Grant. Dr. Des Weighill is a post-doctoral fellow in Yeh lab. Warmest congratulations on … Continued
-
Yi Presents at The AACR Conference
We are so proud of Yi Xu for his fantastic oral presentation at the AACR Pancreatic Cancer Conference, (September 2022)
-
Congratulations to Mariaelena
Congratulations to Mariaelena on The PanCAN Early Career Diversity Underrepresented Minority Travel Scholarship to the AACR Pancreatic Cancer Conference (August 2022)
-
Yeh, Maduekwe selected as inaugural recipients of the Lustgarten Foundation’s LEAD Project grant
Yeh, Maduekwe selected as inaugural recipients of the Lustgarten Foundation’s LEAD Project grant
-
2021 World Pancreatic Cancer Day
2021 World Pancreatic Cancer Day Raising awareness for the fight against pancreatic cancer on World Pancreatic Cancer Day with our fellow Tar Heels at the UNC Lineberger Pancreatic Cancer Center of Excellence.
PANCREATIC CANCER NEWS
- Differential integrated stress response and asparagine production drive symbiosis and therapy resistance of pancreatic adenocarcinoma cells
- CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer
- Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1